JAMP VALPROIC ACID ORAL SOLUTION DIN 02532441
Status: Marketed
Holder: JAMP PHARMA CORPORATION
Molecule: VALPROIC ACID (SODIUM VALPROATE)
Available to quote
Health Canada record
| Active ingredient(s) | VALPROIC ACID (SODIUM VALPROATE) 250 MG |
|---|---|
| Dosage form | Solution |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N03AG01 VALPROIC ACID |
| Original market date | 05-Oct-2023 |
| Current status date | 05-Oct-2023 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jamp Pharma Corporation — licence 100590, currently licensed, last inspection rating C (2025-01-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing VALPROIC ACID (SODIUM VALPROATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00443832 | DEPAKENE | BGP PHARMA ULC | Solution | VALPROIC ACID (SODIUM VALPROATE) 250 MG | Marketed |
| 02549190 | ODAN-VALPROIC ACID | ODAN LABORATORIESLTD | Solution | VALPROIC ACID (SODIUM VALPROATE) 250 MG | Marketed |
| 02236807 | PMS-VALPROIC ACID | PHARMASCIENCE INC | Solution | VALPROIC ACID (SODIUM VALPROATE) 250 MG | Marketed |
| 02238069 | VALPROIC ACID ORAL SOLUTION | APOTEX INC | Solution | VALPROIC ACID (SODIUM VALPROATE) 250 MG | Approved |
| 02238370 | APO-VALPROIC ACID ORAL SOLUTION | APOTEX INC | Solution | VALPROIC ACID (SODIUM VALPROATE) 250 MG | Dormant |
| 00443840 | DEPAKENE | BGP PHARMA ULC | Capsule | VALPROIC ACID (SODIUM VALPROATE) 250 MG | Cancelled Post Market |
| 02238042 | DEPROIC SYRUP | TECHNILAB PHARMA INC. | Syrup | VALPROIC ACID (SODIUM VALPROATE) 250 MG | Cancelled Post Market |
| 02238817 | DOM-VALPROIC ACID | DOMINION PHARMACAL | Solution | VALPROIC ACID (SODIUM VALPROATE) 250 MG | Cancelled Post Market |
| 02238368 | EPIJECT I.V. | ABBOTT LABORATORIES, LIMITED | Liquid | VALPROIC ACID (SODIUM VALPROATE) 500 MG | Cancelled Post Market |
| 02238210 | PHL-VALPROIC ACID | PHARMEL INC | Syrup | VALPROIC ACID (SODIUM VALPROATE) 250 MG | Cancelled Post Market |
| 02140063 | RATIO-VALPROIC 50MG/ML SYRUP | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Syrup | VALPROIC ACID (SODIUM VALPROATE) 50 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 29338 | 2022-10-31 | Abbreviated New Drug Submission (ANDS) |